Weight loss drugs could be a gamechanger for women with a common hormonal disorder
-
最新报道：New research suggests GLP-1 weight-loss drugs like Ozempic and Wegovy may help treat polycystic ovary syndrome (PCOS), a hormonal disorder affecting 1 in 10 women. Early clinical trials show these medications can improve insulin resistance, reduce testosterone levels, and restore menstrual cycles in PCOS patients. Pharmaceutical companies are now accelerating studies to explore this potential new application, with Novo Nordisk planning Phase 3 trials specifically for PCOS treatment. Endocrinologists caution that while results are promising, more long-term data is needed to confirm safety and efficacy for this off-label use. The development could significantly expand the market for GLP-1 drugs beyond diabetes and obesity.
下一篇
Render (RNDR) & Pi Network Are Gaining Traction But One Payment-Powered Altcoin Could Leave Both in the Dust
- Render (RNDR) and Pi Network are gaining traction in the crypto space, but a new payment-f...
24小时热点
热点专题
418154